Journal article · 2026

Anti-CLEC7A nanobody in situ engineering promotes amyloid-β oligomers clearance by CAR-microglia to alleviate Alzheimer's disease pathology in mice

Chongzheng Yan, Zhichao Kong, Yuxue Pan, Zhipeng Fu, Kun Han, Xiaotian Zhao, Jing Zhang, Longyu Bo, 孙维绎, Jinxin Gao, Xianghui Dong, Zuolin Zheng and 4 more

Journal of Controlled Release, 392, 114710 · Published 15 February 2026 · DOI 10.1016/j.jconrel.2026.114710

View at the publisherCite this paper

In brief

“Anti-CLEC7A nanobody in situ engineering promotes amyloid-β oligomers clearance by CAR-microglia to alleviate Alzheimer's disease pathology in mice” is a 2026 journal article by Chongzheng Yan and 15 co-authors, published in Journal of Controlled Release. OpenAlex counts 8 citations as of 18 November 2026, which puts it in the top 2% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
8
Most cited in
2026 (8)
Field-weighted impact
11.14
References
22
Authors
16

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Yan, C., Kong, Z., Pan, Y., Fu, Z., Han, K., Zhao, X., Zhang, J., Bo, L., 孙维绎, Gao, J., Dong, X., Zheng, Z., Yue, X., Sun, P., Jiang, X., & Chen, C. (2026). Anti-CLEC7A nanobody in situ engineering promotes amyloid-β oligomers clearance by CAR-microglia to alleviate Alzheimer's disease pathology in mice. Journal of Controlled Release, 392, 114710. https://doi.org/10.1016/j.jconrel.2026.114710

MLA 9

Yan, Chongzheng, et al. “Anti-CLEC7A nanobody in situ engineering promotes amyloid-β oligomers clearance by CAR-microglia to alleviate Alzheimer's disease pathology in mice.” Journal of Controlled Release, vol. 392, 2026, p. 114710. https://doi.org/10.1016/j.jconrel.2026.114710.

Chicago

Yan, Chongzheng, Zhichao Kong, Yuxue Pan, Zhipeng Fu, Kun Han, Xiaotian Zhao, Jing Zhang, et al. 2026. “Anti-CLEC7A nanobody in situ engineering promotes amyloid-β oligomers clearance by CAR-microglia to alleviate Alzheimer's disease pathology in mice.” Journal of Controlled Release 392: 114710. https://doi.org/10.1016/j.jconrel.2026.114710.

Harvard

Yan, C. et al. (2026) ‘Anti-CLEC7A nanobody in situ engineering promotes amyloid-β oligomers clearance by CAR-microglia to alleviate Alzheimer's disease pathology in mice’, Journal of Controlled Release, 392, p. 114710. doi:10.1016/j.jconrel.2026.114710.

IEEE

C. Yan et al., “Anti-CLEC7A nanobody in situ engineering promotes amyloid-β oligomers clearance by CAR-microglia to alleviate Alzheimer's disease pathology in mice,” Journal of Controlled Release, vol. 392, p. 114710, 2026, doi: 10.1016/j.jconrel.2026.114710.

BibTeX

@article{yan2026anti,
  title     = {{Anti-CLEC7A nanobody in situ engineering promotes amyloid-β oligomers clearance by CAR-microglia to alleviate Alzheimer's disease pathology in mice}},
  author    = {Yan, Chongzheng and Kong, Zhichao and Pan, Yuxue and Fu, Zhipeng and Han, Kun and Zhao, Xiaotian and Zhang, Jing and Bo, Longyu and 孙维绎 and Gao, Jinxin and Dong, Xianghui and Zheng, Zuolin and Yue, Xiao and Sun, Peng and Jiang, Xinyi and Chen, Chen},
  journal   = {Journal of Controlled Release},
  year      = {2026},
  volume    = {392},
  pages     = {114710},
  doi       = {10.1016/j.jconrel.2026.114710},
  url       = {https://doi.org/10.1016/j.jconrel.2026.114710}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease
  • amyloid-beta oligomers
  • Dectin-1
  • nanobodies
  • lipid nanoparticles
  • intranasal drug delivery
  • phagocytosis
  • APP/PS1 mice

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Yan, C., Kong, Z., Pan, Y., Fu, Z., Han, K., Zhao, X., Zhang, J., Bo, L., 孙维绎, Gao, J., Dong, X., Zheng, Z., Yue, X., Sun, P., Jiang, X., & Chen, C. (2026). Anti-CLEC7A nanobody in situ engineering promotes amyloid-β oligomers clearance by CAR-microglia to alleviate Alzheimer's disease pathology in mice. Journal of Controlled Release, 392, 114710. https://doi.org/10.1016/j.jconrel.2026.114710

How many times has this paper been cited?

8 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Chongzheng Yan, Zhichao Kong, Yuxue Pan, Zhipeng Fu, Kun Han, Xiaotian Zhao, Jing Zhang, Longyu Bo, 孙维绎, Jinxin Gao, Xianghui Dong, Zuolin Zheng and 4 more.

What is the DOI of this paper?

10.1016/j.jconrel.2026.114710, permanently at https://doi.org/10.1016/j.jconrel.2026.114710. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.